Chapter 1. Introduction
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
1.3.1. Market research process
1.3.2. Market research methodology
Chapter 2. Executive Summary
2.1. Global Neuroscience Market, 2016 - 2024 (USD Million)
2.2. Global Neuroscience Market: Snapshot
Chapter 3. Neurosciences- Market Dynamics
3.1. Introduction
3.2. Market drivers
3.2.1. Global Neuroscience Market drivers: Impact analysis
3.2.2. The rise in the incidence of cerebral stroke and other severe disorders
3.2.3. Advancements in technology drive the market
3.3. Market Restraints
3.3.1. Global Neuroscience Market restraints: Impact analysis
3.3.2. The high cost of instruments
3.4. Opportunities
3.4.1. Wearable Technologies
3.5. Porters five forces analysis
3.5.1. Bargaining power of suppliers
3.5.2. Bargaining power of buyers
3.5.3. The threat from new entrants
3.5.4. The threat from new substitutes
3.5.5. Degree of competition
3.6. Market attractiveness analysis
3.6.1. Market attractiveness analysis, by component segment
3.6.2. Market attractiveness analysis, by End-user segment
3.6.3. Market attractiveness analysis, by regional segment
Chapter 4. Global Neuroscience Market - Competitive Landscape
4.1. Company Market Share Analysis
4.1.1. Global Neuroscience Market: company market share, 2016
4.2. Strategic Development
4.2.1. Acquisitions Mergers
4.2.2. New Therapy Launch
4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
4.2.4. Research and Development, Therapy and Regional Expansion
4.3. Price Trend Analysis
4.4. Technology Portfolio
Chapter 5. Global Neuroscience Market - Component Segment Analysis
5.1. Global Neuroscience Market: a Component overview
5.1.1. Global Neuroscience Market revenue share, by Component, 2016 and 2024
5.2. Instrument
5.2.1. Global Instrument market, 2016 - 2024(USD Million)
5.3. Software
5.3.1. Global Software market, 2016 - 2024(USD Million)
5.4. Services
5.4.1. Global Services market, 2016 - 2024(USD Million)
Chapter 6. Global Neuroscience Market - End-user Segment Analysis
6.1. Global Neuroscience Market: End-user overview
6.1.1. Global Neuroscience Market revenue share, by End-user, 2016 and 2024
6.2. Hospitals
6.2.1. Global Hospitals market , 2016 - 2024(USD Million)
6.3. Diagnostic Laboratories
6.3.1. Global Diagnostic Laboratories market , 2016 - 2024(USD Million)
6.4. Research Institutes
6.4.1. Global Research Institutesmarket , 2016 - 2024(USD Million)
6.5. Academic Institutes
6.5.1. Global Academic Institutes market , 2016 - 2024(USD Million)
Chapter 7. Global Neuroscience Market - Regional Segment Analysis
7.1. Global Neuroscience Market: Regional overview
7.1.1. Global Neuroscience Market revenue share, by region, 2016 and 2024
7.2. North America
7.2.1. North America Neuroscience Market revenue, by Component, 2014 - 2024 (USD Million)
7.2.2. North America Neuroscience Market revenue, by End-user, 2014 - 2024 (USD Million)
7.2.3. U.S.
7.2.4. Rest of North America
7.3. Europe
7.3.1. Europe Neuroscience Market revenue, by Component, 2014 - 2024(USD Million)
7.3.2. Europe Neuroscience Market revenue, by End-user, 2014 - 2024(USD Million)
7.3.3. Germany
7.3.4. UK
7.3.5. France
7.3.6. Italy
7.3.7. Spain
7.3.8. Russia
7.4. Asia Pacific
7.4.1. Asia Pacific Neuroscience Market revenue, by Component, 2014 - 2024, (USD Million)
7.4.2. Asia Pacific Neuroscience Market revenue, by End-user, 2014 - 2024, (USD Million)
7.4.3. China
7.4.4. Japan
7.4.5. India
7.4.6. South East Asia
7.4.7. Rest of Asia Pacific
7.5. Latin America
7.5.1. Latin America Neuroscience Market revenue, by Component, 2014 - 2024(USD Million)
7.5.2. Latin America Neuroscience Market revenue, by End-user, 2014 - 2024(USD Million)
7.5.3. Brazil
7.5.4. Rest of Latin America
7.6. Middle East and Africa
7.6.1. Middle East and Africa Neuroscience Market revenue, by Component, 2014 - 2024 (USD Million)
7.6.2. Middle East and Africa Neuroscience Market revenue, by End-user, 2014 - 2024 (USD Million)
7.6.3. GCC Countries
7.6.4. South Africa
7.6.5. Rest of Middle East Africa
Chapter 8. Company Profile
8.1. Alpha Omega
8.1.1. Overview
8.1.2. Financials
8.1.3. Product portfolio
8.1.4. Business strategy
8.1.5. Recent developments
8.2. AxionBioSystems, Inc.
8.2.1. Overview
8.2.2. Financials
8.2.3. Product portfolio
8.2.4. Business strategy
8.2.5. Recent developments
8.3. Blackrock Microsystems LLC
8.3.1. Overview
8.3.2. Financials
8.3.3. Product portfolio
8.3.4. Business strategy
8.3.5. Recent developments
8.4. Femtonics Ltd.
8.4.1. Overview
8.4.2. Financials
8.4.3. Product portfolio
8.4.4. Business strategy
8.4.5. Recent developments
8.5. NeuroNexus (Nuvectra)
8.5.1. Overview
8.5.2. Financials
8.5.3. Product portfolio
8.5.4. Business strategy
8.5.5. Recent developments
8.6. Neurotar
8.6.1. Overview
8.6.2. Financials
8.6.3. Product portfolio
8.6.4. Business strategy
8.6.5. Recent developments
8.7. Newport Corporation
8.7.1. Overview
8.7.2. Financials
8.7.3. Product portfolio
8.7.4. Business strategy
8.7.5. Recent developments
8.8. Plexon Inc.
8.8.1. Overview
8.8.2. Financials
8.8.3. Product portfolio
8.8.4. Business strategy
8.8.5. Recent developments
8.9. Intan Technologies, LLC
8.9.1. Overview
8.9.2. Financials
8.9.3. Product portfolio
8.9.4. Business strategy
8.9.5. Recent developments
8.10. LaVisionBioTec GmbH
8.10.1. Overview
8.10.2. Financials
8.10.3. Product portfolio
8.10.4. Business strategy
8.10.5. Recent developments
8.11. Neuralynx, Inc.
8.11.1. Overview
8.11.2. Financials
8.11.3. Product portfolio
8.11.4. Business strategy
8.11.5. Recent developments
8.12. Scientifica Ltd
8.12.1. Overview
8.12.2. Financials
8.12.3. Product portfolio
8.12.4. Business strategy
8.12.5. Recent developments
8.13. Trifoil Imaging Inc
8.13.1. Overview
8.13.2. Financials
8.13.3. Product portfolio
8.13.4. Business strategy
8.13.5. Recent developments
8.14. Thomas Recording GmbH
8.14.1. Overview
8.14.2. Financials
8.14.3. Product portfolio
8.14.4. Business strategy
8.14.5. Recent developments
8.15. Sutter Instrument Corporation
8.15.1. Overview
8.15.2. Financials
8.15.3. Product portfolio
8.15.4. Business strategy
8.15.5. Recent developments
